H.R.841 is a bill to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021”.

SECTION 2. USE OF HEMP AND CANNABIDIOL DERIVED FROM HEMP AS DIETARY INGREDIENT

(a) In General — Beginning on the date that is 90 days after the date of enactment of this Act, notwithstanding section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(ff)(3)(B)), hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp shall be lawful for use under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) as a dietary ingredient in a dietary supplement, provided that such dietary supplement complies with—

(1) the requirements for a dietary supplement which contains a new dietary ingredient in section 413 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350b); and

(2) all other applicable requirements for a dietary supplement in the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Fair Packaging and Labeling Act (15 U.S.C. 1451 et seq.).

(b) Definitions — In this section:

(1) DIETARY SUPPLEMENT. —The term “dietary supplement” has the meaning given such term in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321).

(2) HEMP — The term “hemp” has the meaning given such term in section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o).

(3) NEW DIETARY INGREDIENT — The term “new dietary ingredient” has the meaning given such term in section 413 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350b).